Lipid-lowering properties of 6-benzoyl-2(3H)-benzothiazolone and structurally related compounds

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 6, 2005, Pages 525-532

  Yous, Saïd ^a   Lebegue, Nicolas ^a   Poupaert, Jacques Henry ^b   Chavatte, Philippe ^a   Berthelot, Pascal ^a  

^a UNIV LILLE   (France)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

2(3H) benzothiazolone; Cholesterol; Clofibrate; Fenofibrate; Normolipemic

Indexed keywords

6 (2 METHYLENEBUTYRYL) 2(3H) BENZOTHIAZOLONE; 6 (4 BROMOBUTYRYL) 2(3H) BENZOTHIAZOLONE; 6 [(2 DIMETHYLAMINOMETHYL)BUTYRYL] 2(3H) BENZOTHIAZOLONE; 6 [(2 ETHYLTHIOMETHYL)BUTYRYL] 2(3H) BENZOTHIAZOLONE; 6 [4 (4 PHENYLPIPERAZIN 1 YL)BUTYRYL] 2(3H) BENZOTHIAZOLONE; 6 BENZOYL 2(3H) BENZOTHIAZOLONE DERIVATIVE; 6 N BUTYL 2(3H) BENZOTHIAZOLONE; 7 ACYL 1,4 BENZOXAZIN 3(4H) ONE; ANTILIPEMIC AGENT; BENZOTHIAZOLE DERIVATIVE; BENZOXAZINE DERIVATIVE; CHOLESTEROL; CLOFIBRATE; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; 6 BENZOYL 2(3H) BENZOTHIAZOLONE; 6-BENZOYL-2(3H)-BENZOTHIAZOLONE; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESPONSE; DRUG STRUCTURE; FEMALE; HEPATOMEGALY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; BODY WEIGHT; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DIET; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; ORGAN SIZE; SYNTHESIS;

ANIMALS; ANTILIPEMIC AGENTS; BENZOTHIAZOLES; BODY WEIGHT; DIET; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; HYPERCHOLESTEROLEMIA; LIPIDS; MICE; MOLECULAR STRUCTURE; ORGAN SIZE; THIAZOLES;

EID: 33644987622     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/03067310500212037     Document Type: Article

References (29)

1. Kannel, B and Castelli, WP and Gordon, T. (1971) Ann Intern Med, 74, pp. 1-12.
2. Miller, NE and Forde, OH and Thelle, DS and Mjos, OD. (1977) Lancet, 1, pp. 965-968.
3. Goldbourt, V and Medalie, J. (1979) Ann J Epidemiol, 109, pp. 296-308.
4. Peto, R and Yusuf, S and Collins, R. (1985) Circulation, 72, pp. 111-451.
5. Scott, R. (1997) Clin Exp Pharmacol Physicol, 24, pp. A26-A28.
6. Bittner, V and Simon, JA and Fong, J and Blumenthal, RS and Newby, K and Stefanick, ML. (2000) Am Heart J, 139, pp. 288-296.
7. Chong, PH and Bachenheimer, BS. (2000) Drugs, 60, pp. 55-93.
8. Milionis, HJ and Elisaf, MS and Mikhailidis, DP. (2000) Curr Med Res Opin, 16, pp. 21-32.
9. Staels, B and Auwerx, J. (1997) Curr Pharm Des, 3, pp. 1-14.
10. Witiak, DT and Stratford, ES and Nazareth, R and Wagner, G and Feller, DR. (1971) J Med Chem, 14, pp. 758-766.
11. Newman, HAI and Heilman, WP and Witiak, DT. (1973) Lipids, 8, pp. 378-384.
12. Witiak, DT and Heilman, WP and Sankarappa, SK and Cavestri, RC and Newman, HAI. (1975) J Med Chem, 18, pp. 934-942.
13. Witiak, DT and Poochikian, GK and Feller, DR and Kenfield, NA and Newman, HAI. (1975) J Med Chem, 18, pp. 992-996.
14. Witiak, DT and Kuwano, E and Feller, DR and Baldwin, JR and Newman, HAI and Sarlkarappa, SK. (1976) J Med Chem, 19, pp. 1214-1220.
15. Goldberg, AP and Mellon, WS and Witiak, DT and Feller, DR. (1977) Atherosclerosis, 27, pp. 15-25.
16. Moussavi, Z and Lesieur, D and Lespagnol, C and Sauzières, J and Olivier, P. (1989) Eur J Med Chem, 24, pp. 55-60.
17. Moussavi, Z and Plancke, MO and Olivier, P and Lesieur, D and Fruchart, JC and Sauzières, J. (1989) Clin Chim Acta, 180, pp. 35-44.
18. Moussavi, Z and Depreux, P and Lesieur, D and Cotelle, N and Sauzières, J and Plancke, MO and Fruchart, JC. (1991) Farmaco, 46, pp. 339-355.
19. Yous, S and Poupaert, JH and Lesieur, I and Depreux, P and Lesieur, D. (1994) J Org Chem, 59, pp. 1574-1576.
20. Diouf, O and Depreux, P and Lesieur, D and Poupaert, JH and Caignard, DH. (1995) Eur J Med Chem, 30, pp. 715-720.
21. Kanyonyo, MR and Ucar, H and Issa, M and Carato, P and Lesieur, D and Renard, P and Poupaert, JH. (1996) J Bull Soc Chim Belg, 105, pp. 17-22.
22. West, CT and Donelly, SJ and Kooistra, DA and Doyle, MP. (1973) J Org Chem, 38, pp. 2675-2681.
23. Hansch, C and Clayton, JM. (1973) J Pharm Sci, 62, pp. 1-21.
24. Lalwani, ND and Redy, MK and Qureschi, SA and Sirotori, CR and Abiko, Y and Reddy, JK. (1983) Hum Toxicol, 2, pp. 27-48.
25. Olivier, P and Plancke, MO and Marzin, D and Clavey, V and Sauzieres, J and Fruchart, JC. (1988) Atherosclerosis, 70, pp. 107-114.
26. Burstein, M and Scholnick, HR and Morfin, R. (1970) J Lipid Res, 11, pp. 538-595.
27. Plancke, MO and Olivier, P and Clavey, V and Marzin, D and Fruchart, JC. (1988) Meth Find Exp Clin Pharmacol, 10, pp. 575-579.
28. Schwartz, D and Lazar, P. (1971) Eléments de statistique médicale et biologique 4ème éditition. Paris: Flammarion Médecine-Sciences.
29. Scherrer, B. (1984) Biostatistique. Chicoutimi: Gaëtan Morin.